Min Zhu

Practice Areas

Life Sciences and healthcare, Corporate compliance, Venture capital and private equity, Mergers and acquisitions, Foreign direct investment

Career

Mr. Zhu is an experienced lawyer who specializes in advising Chinese and multinational corporations on their business investments, transactions, and compliance matters, including corporate compliance, private equity investment, foreign direct investment, mergers and acquisitions, and corporate restructuring. His clients cover a wide range of industries, including pharmaceuticals, medical devices, foods, automobiles, logistics, TMT, retail, and international trade. Mr. Zhu has been consistently recognized as a highly recommended practitioner in life sciences, healthcare, and corporate compliance by leading global legal ranking organizations such as Chambers and Partners and The Legal 500.

Mr. Zhu has particular expertise in advising healthcare and life science companies in their various stages of development, including financing and license-in deals for start-up companies, mergers and acquisitions, and various regulatory and compliance matters, such as anti-corruption and anti-bribery, clinical trials, drug and medical device registration, distribution, advertising and promotion.

Mr. Zhu is also well-versed in data compliance matters, having served Chinese and multinational corporations in dozens of data compliance projects, including data compliance analysis, formulating corporate internal data protection and compliance programs, data legal due diligence, handling data incident crises, and drafting data agreements and standard data protection clauses. His work in this area has included industries such as banking, technology, travel, retail, hospitality, medical services, pharmaceuticals, genetics testing, personal credit evaluation, AI driving, Internet mapping, fund management, online payments, and precision marketing, etc.

Professional Memberships

Member of the PRC Bar

Publications

The Healthcare Law Review – China, 1st to 8th editions (2017 - 2024)

Chambers Life Sciences: China Trends & Developments (2022 - 2025)

The Legal 500: Life Sciences Guide 2024

Languages Spoken

Chinese, English

Awards

Education